Review



sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant  (Novavax Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novavax Inc sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant
    Sars Cov 2 Recombinant Spike Protein Nanoparticle Vaccine (Sars Cov 2 Rs) With Matrix M1tm Adjuvant, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant  (Novavax Inc)
    90
    Novavax Inc sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant
    Sars Cov 2 Recombinant Spike Protein Nanoparticle Vaccine (Sars Cov 2 Rs) With Matrix M1tm Adjuvant, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1tm adjuvant - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    matrix-m–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373  (Novavax Inc)
    90
    Novavax Inc matrix-m–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373
    Matrix M–Adjuvanted Recombinant Spike (Rs) Protein Nanoparticle Covid 19 Vaccine Nvx Cov2373, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matrix-m–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    matrix-m–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    matrixm–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373  (Novavax Inc)
    90
    Novavax Inc matrixm–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373
    Matrixm–Adjuvanted Recombinant Spike (Rs) Protein Nanoparticle Covid 19 Vaccine Nvx Cov2373, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matrixm–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    matrixm–adjuvanted recombinant spike (rs) protein nanoparticle covid-19 vaccine nvx-cov2373 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    recombinant spike protein nanoparticle vaccine  (Novavax Inc)
    90
    Novavax Inc recombinant spike protein nanoparticle vaccine
    Recombinant Spike Protein Nanoparticle Vaccine, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant spike protein nanoparticle vaccine/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    recombinant spike protein nanoparticle vaccine - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    recombinant spike (rs) protein nanoparticle vaccine nvxcov2373  (Novavax Inc)
    90
    Novavax Inc recombinant spike (rs) protein nanoparticle vaccine nvxcov2373
    Recombinant Spike (Rs) Protein Nanoparticle Vaccine Nvxcov2373, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant spike (rs) protein nanoparticle vaccine nvxcov2373/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    recombinant spike (rs) protein nanoparticle vaccine nvxcov2373 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    nanoparticle recombinant spike (s) protein-based covid-19 vaccine  (Novavax Inc)
    90
    Novavax Inc nanoparticle recombinant spike (s) protein-based covid-19 vaccine
    Nanoparticle Recombinant Spike (S) Protein Based Covid 19 Vaccine, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nanoparticle recombinant spike (s) protein-based covid-19 vaccine/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    nanoparticle recombinant spike (s) protein-based covid-19 vaccine - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    sars-cov-2 recombinant spike protein nanoparticle vaccine  (Novavax Inc)
    90
    Novavax Inc sars-cov-2 recombinant spike protein nanoparticle vaccine
    Annual trends and topics of global publications. (A) Annual publications and the fitting equation for annual publications. The trend of annual publications is fitted using the exponential trendline type in Excel, where a higher R² value indicates a more precise alignment between the regression line and observed values. (B) Term contributions in nanovaccine research from 2020 to 2023. The terms were extracted from the title and abstract. Each node symbolizes a term, with the node’s dimensions mirroring its overall frequency. The color designates the frequency of each term in the period from 2020 to 2023 relative to its overall frequency. The proportion associated with each color is depicted at the bottom right of the figure. The closer the color is to red, the higher the proportion. For example, “lipid <t>nanoparticle”</t> appeared 128 times from 1981 to 2023, with 111 occurrences between 2020 and 2023, constituting 86.72%, and is therefore shown in red on the graph. The interpretation of this graph can be enhanced by considering both the size and color of the nodes: the larger and redder the node, the more prominent the term was as a research focus from 2020 to 2023. The detailed methodology is provided in <xref ref-type= Supplementary Material 1 .. " width="250" height="auto" />
    Sars Cov 2 Recombinant Spike Protein Nanoparticle Vaccine, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars-cov-2 recombinant spike protein nanoparticle vaccine/product/Novavax Inc
    Average 90 stars, based on 1 article reviews
    sars-cov-2 recombinant spike protein nanoparticle vaccine - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Annual trends and topics of global publications. (A) Annual publications and the fitting equation for annual publications. The trend of annual publications is fitted using the exponential trendline type in Excel, where a higher R² value indicates a more precise alignment between the regression line and observed values. (B) Term contributions in nanovaccine research from 2020 to 2023. The terms were extracted from the title and abstract. Each node symbolizes a term, with the node’s dimensions mirroring its overall frequency. The color designates the frequency of each term in the period from 2020 to 2023 relative to its overall frequency. The proportion associated with each color is depicted at the bottom right of the figure. The closer the color is to red, the higher the proportion. For example, “lipid nanoparticle” appeared 128 times from 1981 to 2023, with 111 occurrences between 2020 and 2023, constituting 86.72%, and is therefore shown in red on the graph. The interpretation of this graph can be enhanced by considering both the size and color of the nodes: the larger and redder the node, the more prominent the term was as a research focus from 2020 to 2023. The detailed methodology is provided in <xref ref-type= Supplementary Material 1 .. " width="100%" height="100%">

    Journal: Frontiers in Immunology

    Article Title: A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

    doi: 10.3389/fimmu.2024.1420216

    Figure Lengend Snippet: Annual trends and topics of global publications. (A) Annual publications and the fitting equation for annual publications. The trend of annual publications is fitted using the exponential trendline type in Excel, where a higher R² value indicates a more precise alignment between the regression line and observed values. (B) Term contributions in nanovaccine research from 2020 to 2023. The terms were extracted from the title and abstract. Each node symbolizes a term, with the node’s dimensions mirroring its overall frequency. The color designates the frequency of each term in the period from 2020 to 2023 relative to its overall frequency. The proportion associated with each color is depicted at the bottom right of the figure. The closer the color is to red, the higher the proportion. For example, “lipid nanoparticle” appeared 128 times from 1981 to 2023, with 111 occurrences between 2020 and 2023, constituting 86.72%, and is therefore shown in red on the graph. The interpretation of this graph can be enhanced by considering both the size and color of the nodes: the larger and redder the node, the more prominent the term was as a research focus from 2020 to 2023. The detailed methodology is provided in Supplementary Material 1 ..

    Article Snippet: Phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine , 2020 , 701 , Keech, C , Novavax , USA , New England Journal of Medicine.

    Techniques:

    Information on the top 7 clusters in the co-cited authors’ network.

    Journal: Frontiers in Immunology

    Article Title: A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

    doi: 10.3389/fimmu.2024.1420216

    Figure Lengend Snippet: Information on the top 7 clusters in the co-cited authors’ network.

    Article Snippet: Phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine , 2020 , 701 , Keech, C , Novavax , USA , New England Journal of Medicine.

    Techniques:

    The top 20 publications in number of total citations.

    Journal: Frontiers in Immunology

    Article Title: A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

    doi: 10.3389/fimmu.2024.1420216

    Figure Lengend Snippet: The top 20 publications in number of total citations.

    Article Snippet: Phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine , 2020 , 701 , Keech, C , Novavax , USA , New England Journal of Medicine.

    Techniques: Activation Assay, Vaccines, Membrane, Recombinant, Blocking Assay, Immunopeptidomics, In Vitro, In Vivo, Liposomes, Adjuvant, Modification, Bioprocessing, Infection, Molecular Weight

    The top 10 co-cited references in #2, #3, and #5 clusters.

    Journal: Frontiers in Immunology

    Article Title: A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

    doi: 10.3389/fimmu.2024.1420216

    Figure Lengend Snippet: The top 10 co-cited references in #2, #3, and #5 clusters.

    Article Snippet: Phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine , 2020 , 701 , Keech, C , Novavax , USA , New England Journal of Medicine.

    Techniques: Vaccines, In Vivo, Polymer, Immunopeptidomics, Membrane, Adjuvant, Modification, Virus, Binding Assay, Bioprocessing, Infection

    Top ten co-cited references in nanovaccine research.

    Journal: Frontiers in Immunology

    Article Title: A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

    doi: 10.3389/fimmu.2024.1420216

    Figure Lengend Snippet: Top ten co-cited references in nanovaccine research.

    Article Snippet: Phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine , 2020 , 701 , Keech, C , Novavax , USA , New England Journal of Medicine.

    Techniques: Vaccines, Drug discovery